151 related articles for article (PubMed ID: 26549062)
21. Fluorescent in situ hybridization and ex vivo 1H magnetic resonance spectroscopic examinations of meningioma tumor tissue: is it possible to identify a clinically-aggressive subset of benign meningiomas?
Pfisterer WK; Hendricks WP; Scheck AC; Nieman RA; Birkner TH; Krampla WW; Preul MC
Neurosurgery; 2007 Nov; 61(5):1048-59; discussion 1060-1. PubMed ID: 18091281
[TBL] [Abstract][Full Text] [Related]
22. Allelic losses at 1p, 9q, 10q, 14q, and 22q in the progression of aggressive meningiomas and undifferentiated meningeal sarcomas.
Lamszus K; Kluwe L; Matschke J; Meissner H; Laas R; Westphal M
Cancer Genet Cytogenet; 1999 Apr; 110(2):103-10. PubMed ID: 10214357
[TBL] [Abstract][Full Text] [Related]
23. Loss of material from chromosome arm 1p during malignant progression of meningioma revealed by fluorescent in situ hybridization.
Ishino S; Hashimoto N; Fushiki S; Date K; Mori T; Fujimoto M; Nakagawa Y; Ueda S; Abe T; Inazawa J
Cancer; 1998 Jul; 83(2):360-6. PubMed ID: 9669820
[TBL] [Abstract][Full Text] [Related]
24. A consistent region of deletion on 1p36 in meningiomas: identification and relation to malignant progression.
Murakami M; Hashimoto N; Takahashi Y; Hosokawa Y; Inazawa J; Mineura K
Cancer Genet Cytogenet; 2003 Jan; 140(2):99-106. PubMed ID: 12645646
[TBL] [Abstract][Full Text] [Related]
25. Chromosomal aberrations in chordoid meningioma - An analysis.
Sugur H; Shastry AH; Sadashiva N; Srinivas D; Santosh V; Somanna S
Neurol India; 2018; 66(1):156-160. PubMed ID: 29322978
[TBL] [Abstract][Full Text] [Related]
26. Molecular biological determinations of meningioma progression and recurrence.
Linsler S; Kraemer D; Driess C; Oertel J; Kammers K; Rahnenführer J; Ketter R; Urbschat S
PLoS One; 2014; 9(4):e94987. PubMed ID: 24722350
[TBL] [Abstract][Full Text] [Related]
27. Loss of heterozygosity of chromosome 14q in low- and high-grade meningiomas.
Tse JY; Ng HK; Lau KM; Lo KW; Poon WS; Huang DP
Hum Pathol; 1997 Jul; 28(7):779-85. PubMed ID: 9224744
[TBL] [Abstract][Full Text] [Related]
28. Detection of chromosome 1p deletion using FISH on meningioma touch imprints suggest a region outside chromosome 22 as important in tumor recurrence.
Tamiolakis D; Papadopoulos N; Lambropoulou M; Kotini A; Simopoulos C
Minerva Med; 2003 Feb; 94(1):51-6. PubMed ID: 12719702
[TBL] [Abstract][Full Text] [Related]
29. The correlation of clinical and chromosomal alterations of benign meningiomas and their recurrences.
Och W; Szmuda T; Kulbacki K; Witek K; Sikorska B; Zakrzewska M; Springer J; Reszeć J; Parda A; Liberski PP
Neurol Neurochir Pol; 2016; 50(6):395-402. PubMed ID: 27480481
[TBL] [Abstract][Full Text] [Related]
30. Impact of 1p/19q codeletion on the diagnosis and prognosis of different grades of meningioma.
Basaran R; Uslu S; Gucluer B; Onoz M; Isik N; Tiryaki M; Yakicier C; Sav A; Elmaci I
Br J Neurosurg; 2016 Oct; 30(5):571-6. PubMed ID: 27173440
[TBL] [Abstract][Full Text] [Related]
31. Implicating chromosomal aberrations with meningioma growth and recurrence: results from FISH and MIB-I analysis of grades I and II meningioma tissue.
Pfisterer WK; Coons SW; Aboul-Enein F; Hendricks WP; Scheck AC; Preul MC
J Neurooncol; 2008 Mar; 87(1):43-50. PubMed ID: 18060363
[TBL] [Abstract][Full Text] [Related]
32. Correlation between histological grade and MIB-1 and p53 immunoreactivity in meningiomas.
Ozen O; Demirhan B; Altinörs N
Clin Neuropathol; 2005; 24(5):219-24. PubMed ID: 16167545
[TBL] [Abstract][Full Text] [Related]
33. Recurrence-associated chromosomal anomalies in meningiomas: Single-institution study and a systematic review with meta-analysis.
Och W; Szmuda T; Sikorska B; Springer J; Jaskólski D; Zakrzewska M; Liberski PP
Neurol Neurochir Pol; 2016; 50(6):439-448. PubMed ID: 27575681
[TBL] [Abstract][Full Text] [Related]
34. Fluorescent in situ hybridization 1p/19q deletion/imbalance analysis of low-grade and atypical meningiomas.
Nagasaka T; Gunji M; Hosokai N; Hayashi K; Fujino M; Ikeda H; Ito M; Inao S
Neurol Med Chir (Tokyo); 2010 Jan; 50(1):27-32; discussion 32. PubMed ID: 20098021
[TBL] [Abstract][Full Text] [Related]
35. Intratumoral patterns of clonal evolution in meningiomas as defined by multicolor interphase fluorescence in situ hybridization (FISH): is there a relationship between histopathologically benign and atypical/anaplastic lesions?
Sayagués JM; Tabernero MD; Maíllo A; Espinosa A; Rasillo A; Díaz P; Ciudad J; López A; Merino M; Gonçalves JM; Santos-Briz A; Morales F; Orfao A
J Mol Diagn; 2004 Nov; 6(4):316-25. PubMed ID: 15507670
[TBL] [Abstract][Full Text] [Related]
36. Progesterone and estrogen receptors: opposing prognostic indicators in meningiomas.
Pravdenkova S; Al-Mefty O; Sawyer J; Husain M
J Neurosurg; 2006 Aug; 105(2):163-73. PubMed ID: 17219818
[TBL] [Abstract][Full Text] [Related]
37. Detection of progesterone receptor and the correlation with Ki-67 labeling index in meningiomas.
Mukherjee S; Ghosh SN; Chatterjee U; Chatterjee S
Neurol India; 2011; 59(6):817-22. PubMed ID: 22234191
[TBL] [Abstract][Full Text] [Related]
38. Significance of Simpson grading system in modern meningioma surgery: integration of the grade with MIB-1 labeling index as a key to predict the recurrence of WHO Grade I meningiomas.
Oya S; Kawai K; Nakatomi H; Saito N
J Neurosurg; 2012 Jul; 117(1):121-8. PubMed ID: 22559847
[TBL] [Abstract][Full Text] [Related]
39. [Cytogenetic aberrations in histologically benign infiltratively growing sphenoid wing meningiomas].
Korshunov AG; Cherekaev VA; Bekiashev AKh; Sycheva RV
Zh Vopr Neirokhir Im N N Burdenko; 2007; (4):11-5. PubMed ID: 18274131
[TBL] [Abstract][Full Text] [Related]
40. Genetic and molecular alterations in meningiomas.
Alexiou GA; Markoula S; Gogou P; Kyritsis AP
Clin Neurol Neurosurg; 2011 May; 113(4):261-7. PubMed ID: 21227570
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
